Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

De la Fuente-Gonzalo, F; Nieto, JM; Ricard, P; Anguita, J; Martinez, R; Cervera, A; Villegas, A; Gonzalez, FA; Ropero, P.

Hb Cervantes, Hb Maranon, Hb La Mancha and Hb Goya: Description of 4 new haemoglobinopathies

CLINICAL BIOCHEMISTRY. 2015; 48(10-11): 662-667 Nº de citas: 5 [doi:10.1016/j.clinbiochem.2015.04.020]

SANTIAGO GARCÍA, BEGOÑA; GUERRA SÁNCHEZ, LUIS; Garcia-Morin, M; Gonzalez, E; Gonzalvez, A; Izquierdo, G; Martos, A; SANTOS SEBASTIAN, MAR; NAVARRO GÓMEZ, MARÍA LUISA; HERNÁNDEZ-SAMPELAYO MATOS, TERESA; SAAVEDRA LOZANO, JESÚS.

Clostridium difficile isolation in children hospitalized with diarrhea

ANALES DE PEDIATRIA. 2015; 82(6): 417-425 Nº de citas: 8 [doi:10.1016/j.anpedi.2014.07.015]

Horstmann, K; Boumendil, A; Finke, J; Finel, H; Kanfer, E; Milone, G; Russell, N; Bacigalupo, A; Chalandon, Y; Diez-Martin, JL; Ifrah, N; Chacon, MJ; Dreger, P.

Second allo-SCT in patients with lymphoma relapse after a first allogeneic transplantation. A retrospective study of the EBMT Lymphoma Working Party

BONE MARROW TRANSPLANTATION. 2015; 50(6): 790-794 Nº de citas: 15 [doi:10.1038/bmt.2015.12]

Vallejo, C; Montesinos, P; Polo, M; Cuevas, B; Morado, M; Rosell, A; Xicoy, B; Diez, JL; Salamero, O; Cedillo, A; Martinez, P; Rayon, C.

Rabbit antithymocyte globulin versus horse antithymocyte globulin for treatment of acquired aplastic anemia: a retrospective analysis

ANNALS OF HEMATOLOGY. 2015; 94(6): 947-954 Nº de citas: 37 [doi:10.1007/s00277-015-2305-3]

Valerio M; Muñoz P; Rodríguez CG; Caliz B; Padilla B; Fernández-Cruz A; Sánchez-Somolinos M; Gijón P; Peral J; Gayoso J; Frias I; Salcedo M; Sanjurjo M; Bouza E.

Antifungal stewardship in a tertiary-care institution: a bedside intervention.

CLINICAL MICROBIOLOGY AND INFECTION. 2015; 21(5): Nº de citas: 73 [doi:10.1016/j.cmi.2015.01.013]

Martino, R; Bautista, G; Parody, R; Garcia, I; Esquirol, A; Rovira, M; Cabrera, JR; Regidor, C; Fores, R; Garcia-Marco, JA; Serrano, D; Barba, P; Heras, I; Marquez-Malaver, FJ; Sanchez-Ortega, I; Duarte, R; Saavedra, S; Sierra, J; Vazquez, L.

Severe infections after single umbilical cord blood transplantation in adults with or without the co-infusion of CD34(+) cells from a third-party donor: results of a multicenter study from the Grupo Espanol de Trasplante Hematopoyetico (GETH)

TRANSPLANT INFECTIOUS DISEASE. 2015; 17(2): 221-233 Nº de citas: 7 [doi:10.1111/tid.12361]

Gonzalez-Porras, JR; Mingot-Castellano, ME; Andrade, MM; Alonso, R; Caparros, I; Arratibel, MC; Fernandez-Fuertes, F; Cortti, MJ; Pascual, C; Sanchez-Gonzalez, B; Bernat, S; Fuertes-Palacio, MA; Vazquez-Paganini, JA; Olivera, PE; Alvarez-Roman, MT; Jarque, I; Cortes, M; Martinez-Robles, V; Diaz-Galvez, FJ; Calbacho, M; Fernandez-Minano, C; Garcia-Frade, J; Gonzalez-Lopez, TJ.

Use of eltrombopag after romiplostim in primary immune thrombocytopenia

BRITISH JOURNAL OF HAEMATOLOGY. 2015; 169(1): 111-116 Nº de citas: 62 [doi:10.1111/bjh.13266]

Font, P; Loscertales, J; Soto, C; Ricard, P; Munoz-Novas, C; Martin-Clavero, E; Lopez-Rubio, M; Garcia-Alonso, L; Callejas, M; Bermejo, A; Benavente, C; Ballesteros, M; Cedena, T; Calbacho, M; Urbina, R; Villarrubia, J; Gil, S; Bellon, JM; Diez-Martin, JL; Villegas, A.

Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts

ANNALS OF HEMATOLOGY. 2015; 94(4): 565-573 Nº de citas: 72 [doi:10.1007/s00277-014-2252-4]

Ferra, C; Sanz, J; Diaz-Perez, MA; Morgades, M; Gayoso, J; Cabrera, JR; Villaescusa, T; Sampol, MA; Fernandez-Aviles, F; Solano, C; Ortin, M; Duarte, R; Cuesta, M; Heras, I; de la Serna, J; Moraleda, JM; Barrenetxea, C; Gonzalez-Vicent, M; Sanz, G; Ribera, JM.

Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients

LEUKEMIA & LYMPHOMA. 2015; 56(3): 656-662 Nº de citas: 42 [doi:10.3109/10428194.2014.930849]

Gonzalez-Lopez, TJ; Pascual, C; Alvarez-Roman, MT; Fernandez-Fuertes, F; Sanchez-Gonzalez, B; Caparros, I; Jarque, I; Mingot-Castellano, ME; Hernandez-Rivas, JA; Martin-Salces, M; Solan, L; Beneit, P; Jimenez, R; Bernat, S; Andrade, MM; Cortes, M; Cortti, MJ; Perez-Crespo, S; Gomez-Nunez, M; Olivera, PE; Perez-Rus, G; Martinez-Robles, V; Alonso, R; Fernandez-Rodriguez, A; Arratibel, MC; Perera, M; Fernandez-Minano, C; Fuertes-Palacio, MA; Vazquez-Paganini, JA; Gutierrez-Jomarron, I; Valcarce, I; de Cabo, E; Sainz, A; Fisac, R; Aguilar, C; Martinez-Badas, MP; Penarrubia, MJ; Calbacho, M; de Cos, C; Gonzalez-Silva, M; Coria, E; Alonso, A; Casaus, A; Luana, A; Galan, P; Fernandez-Canal, C; Garcia-Frade, J; Gonzalez-Porras, JR.

Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia

AMERICAN JOURNAL OF HEMATOLOGY. 2015; 90(3): 40-43 Nº de citas: 135 [doi:10.1002/ajh.23900]

Parody, R; Martino, R; de la Camara, R; Garcia-Noblejas, A; Esquirol, A; Garcia-Cadenas, I; Villaescusa, T; Caballero, D; Rovira, M; Fernandez-Aviles, F; Marquez-Malaver, FJ; Espigado, I; Castilla-Llorente, C; Heras, I; Cabero, MA; Cabrera, JR; Barba, P; Valcarcel, D; Sanchez-Ortega, I; Duarte, RF; Serrano, D; Carretero, F; Vazquez, L.

Fungal and viral infections after allogeneic hematopoietic transplantation from unrelated donors in adults: improving outcomes over time

BONE MARROW TRANSPLANTATION. 2015; 50(2): 274-281 Nº de citas: 16 [doi:10.1038/bmt.2014.229]

Gonzalez-Lopez, TJ; Sanchez-Gonzalez, B; Pascual, C; Arefi, M; de Cabo, E; Alonso, A; Martin-Salces, M; Jimenez-Barcenas, R; Calbacho, M; Galan, P; Barez, A; Gonzalez-Porras, JR.

Sustained response after discontinuation of short-and medium-term treatment with eltrombopag in patients with immune thrombocytopenia

PLATELETS. 2015; 26(1): 83-86 Nº de citas: 15 [doi:10.3109/09537104.2013.870987]

de Lorenzo-Pinto, A; Garcia-Sanchez, R; Izquierdo, CP; Duran-Garcia, ME; Castuera-Gil, AI; Andueza-Lillo, JA; Sanjurjo-Saez, M.

Impact of the endorse study results on thromboprophylaxis prescribing patterns in medical patients attending the Emergency Department

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. 2015; 69(1): 81-86 Nº de citas: 2 [doi:10.1111/ijcp.12461]

Martinez-Laperche, C; Noriega, V; Kwon, M; Balsalobre, P; Gonzalez-Rivera, M; Serrano, D; Anguita, J; Gayoso, J; Diez-Martin, JL; Buno, I.

Achievement of early complete donor chimerism in CD25(+)-activated leukocytes is a strong predictor of the development of graft-versus-host-disease after stem cell transplantation

EXPERIMENTAL HEMATOLOGY. 2015; 43(1): 4-13 Nº de citas: 4 [doi:10.1016/j.exphem.2014.09.003]

Kwon, M; Bautista, G; Balsalobre, P; Sanchez-Ortega, I; Serrano, D; Anguita, J; Buno, I; Fores, R; Regidor, C; Marco, JAG; Vilches, C; de Pablo, R; Fernandez, MN; Gayoso, J; Duarte, R; Diez-Martin, JL; Cabrera, R.

Haplo-Cord Transplantation Using CD34(+) Cells from a Third-Party Donor to Speed Engraftment in High-Risk Patients with Hematologic Disorders

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2014; 20(12): 2015-2022 Nº de citas: 39 [doi:10.1016/j.bbmt.2014.08.024]

Martin-Sanchez, E; Odqvist, L; Rodriguez-Pinilla, SM; Sanchez-Beato, M; Roncador, G; Dominguez-Gonzalez, B; Blanco-Aparicio, C; Collazo, AMG; Cantalapiedra, EG; Fernandez, JP; del Olmo, SC; Pisonero, H; Madureira, R; Almaraz, C; Mollejo, M; Alves, FJ; Menarguez, J; Gonzalez-Palacios, F; Rodriguez-Peralto, JL; Ortiz-Romero, PL; Real, FX; Garcia, JF; Bischoff, JR; Piris, MA.

PIM Kinases as Potential Therapeutic Targets in a Subset of Peripheral T Cell Lymphoma Cases

PLoS One. 2014; 9(11): Nº de citas: 20 [doi:10.1371/journal.pone.0112148]

Escudero-Vilaplana V; Osorio Prendes S; Sanjurjo Sáez M.

Posible exantema pruriginoso secundario a lenalidomida.

FARMACIA HOSPITALARIA. 2014; 38(6): 495-496 Nº de citas: 1 [doi:10.7399/fh.2014.38.6.8176]

Garcia-Gutierrez, V; Puerta, JM; Maestro, B; Montero, LFC; Muriel, A; Hurtado, JRM; Perez-Encinas, M; Romero, MVM; Sunol, PB; Garcia, RS; De Paz, R; Sanchez, MJR; Osorio, S; Vazquez, MIM; Lopez, JM; Sastre, JL; Portero, MD; Bautista, G; Nieto, MSD; Giraldo, P; Jambrina, MJ; Burgaleta, C; Aredondo, JR; Penarrubia, MJ; Requena, MJ; Valle, MDF; Calle, C; Coll, AP; Hernandez-Rivas, JA; Osorio, RF; Cano, P; Perez, DT; de la Mata, MF; Garrido, PL; Steegmann, JL.

Do chronic myeloid leukemia patients with late "warning" responses benefit from "watch and wait" or switching therapy to a second generation tyrosine kinase inhibitor?

AMERICAN JOURNAL OF HEMATOLOGY. 2014; 89(11): 206-211 Nº de citas: 5 [doi:10.1002/ajh.23816]